ASN
CMMB

Advisory Services Network’s Chemomab Therapeutics CMMB Stock Holding History

Advisory Services Network’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,197
Closed -$2.44K – 1852
2023
Q4 		$2.44K Sell
1,197
-1,596
-57% -$4.2K ﹤0.01% 3349
2023
Q3 		$10K Hold
2,793
– – ﹤0.01% 1466
2023
Q2 		$14.7K Hold
2,793
– – ﹤0.01% 1427
2023
Q1 		$17.8K Hold
2,793
– – ﹤0.01% 2619
2022
Q4 		$35.8K Hold
2,793
– – ﹤0.01% 2153
2022
Q3 		$28K Hold
2,793
– – ﹤0.01% 1325
2022
Q2 		$41K Buy
+2,793
New +$38.9K ﹤0.01% 1342

Other funds holding CMMB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Advisory Services Network's CMMB Position: Q1 2024 in Review

Advisory Services Network sold out of Chemomab Therapeutics (CMMB) in Q1 2024, closing a stake of 1,197 shares — an estimated $2.44K sold.

Advisory Services Network first reported a position in CMMB in Q2 2022 and held it in 7 quarters. The position peaked at $41K in Q2 2022. 13 funds tracked by Wall St. Rank hold CMMB as of Q1 2024.

  • Advisory Services Network reported no remaining Chemomab Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Advisory Services Network sold 1,197 Chemomab Therapeutics shares in Q1 2024, an estimated $2.44K.
  • Advisory Services Network first reported a position in Chemomab Therapeutics in Q2 2022 and held it in 7 quarters.
  • Advisory Services Network's Chemomab Therapeutics position peaked at $41K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q1 2024.

Based on Advisory Services Network's 13F filing for Q1 2024, filed 6 May 2024.